Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Research and Clinical Oncology
Published in: Journal of Cancer Research and Clinical Oncology 10/2017

01-10-2017 | Review – Cancer Research

Mitochondrial DNA variants in colorectal carcinogenesis: Drivers or passengers?

Authors: Edoardo Errichiello, Tiziana Venesio

Published in: Journal of Cancer Research and Clinical Oncology | Issue 10/2017

Login to get access

Abstract

Introduction

Mitochondrial DNA alterations have widely been reported in many age-related degenerative diseases and tumors, including colorectal cancer. In the past few years, the discovery of inter-genomic crosstalk between nucleus and mitochondria has reinforced the role of mitochondrial DNA variants in perturbing this essential signaling pathway and thus indirectly targeting nuclear genes involved in tumorigenic and invasive phenotype.

Findings

Mitochondrial dysfunction is currently considered a crucial hallmark of carcinogenesis as well as a promising target for anticancer therapy. Mitochondrial DNA alterations include point mutations, deletions, inversions, and copy number variations, but numerous studies investigating their pathogenic role in cancer have provided inconsistent evidence. Furthermore, the biological impact of mitochondrial DNA variants may vary tremendously, depending on the proportion of mutant DNA molecules carried by the neoplastic cells (heteroplasmy).

Conclusions

In this review, we discuss the role of different type of mitochondrial DNA alterations in colorectal carcinogenesis and, in particular, we revisit the issue of whether they may be considered as causative driver or simply genuine passenger events. The advent of high-throughput techniques as well as the development of genetic and pharmaceutical interventions for the treatment of mitochondrial dysfunction in colorectal cancer are also explored.
Literature
Abu-Amero KK, Alzahrani AS, Zou M, Shi Y (2005) High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 24(8):1455–1460PubMedCrossRef
Bellizzi D, D’Aquila P, Giordano M, Montesanto A, Passarino G (2012) Global DNA methylation levels are modulated by mitochondrial DNA variants. Epigenomics 4(1):17–27PubMedCrossRef
Bharti SK, Sommers JA, Zhou J, Kaplan DL, Spelbrink JN, Mergny JL, Brosh RM Jr (2014) DNA sequences proximal to human mitochondrial DNA deletion breakpoints prevalent in human disease form G-quadruplexes, a class of DNA structures inefficiently unwound by the mitochondrial replicative Twinkle helicase. J Biol Chem 289(43):29975–29993PubMedPubMedCentralCrossRef
Brandon M, Baldi P, Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25(34):4647–4662PubMedCrossRef
Chatterjee A, Mambo E, Sidransky D (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25:4663–4674PubMedCrossRef
Cui H, Huang P, Wang Z, Zhang Y, Zhang Z, Xu W, Wang X, Han Y, Guo X (2013) Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer 13:110PubMedPubMedCentralCrossRef
Dames S, Chou LS, Xiao Y, Wayman T, Stocks J, Singleton M, Eilbeck K, Mao R (2013) The development of next-generation sequencing assays for the mitochondrial genome and 108 nuclear genes associated with mitochondrial disorders. J Mol Diagn 15(4):526–534PubMedCrossRef
de Araujo LF, Fonseca AS, Muys BR, Plaça JR, Bueno RB, Lorenzi JC, Santos AR, Molfetta GA, Zanette DL, Souza JE, Valente V, Silva WA Jr (2015) Mitochondrial genome instability in colorectal adenoma and adenocarcinoma. Tumour Biol 36(11):8869–8879PubMedCrossRef
Delsite R, Kachhap S, Anbazhagan R, Gabrielson E, Singh KK (2002) Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol Cancer 1:6PubMedPubMedCentralCrossRef
Desler C, Munch-Petersen B, Stevnsner T, Matsui S, Kulawiec M, Singh KK, Rasmussen LJ (2007) Mitochondria as determinant of nucleotide pools and chromosomal stability. Mutat Res 625(1–2):112–124PubMedCrossRef
Dobson AW, Xu Y, Kelley MR, LeDoux SP, Wilson GL (2000) Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria. J Biol Chem 275(48):37518–37523PubMedCrossRef
Donthamsetty S, Brahmbhatt M, Pannu V, Rida PC, Ramarathinam S, Ogden A, Cheng A, Singh KK, Aneja R (2014) Mitochondrial genome regulates mitotic fidelity by maintaining centrosomal homeostasis. Cell Cycle 13(13):2056–2063PubMedPubMedCentralCrossRef
Druzhyna NM, Musiyenko SI, Wilson GL, LeDoux SP (2005) Cytokines induce nitric oxide-mediated mtDNA damage and apoptosis in oligodendrocytes. Protective role of targeting 8-oxoguanine glycosylase to mitochondria. J Biol Chem 280(22):21673–21679PubMedCrossRef
Dwight T, Mann K, Benn DE, Robinson BG, McKelvie P, Gill AJ, Winship I, Clifton-Bligh RJ (2013) Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. J Clin Endocrinol Metab 98(6):E1103–E1108PubMedCrossRef
Ellinger J, Müller DC, Müller SC, Hauser S, Heukamp LC, von Ruecker A, Bastian PJ, Walgenbach-Brunagel G (2012) Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. Urol Oncol 30(4):509–515PubMedCrossRef
Errichiello E, Balsamo A, Cerni M, Venesio T (2015) Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis. J Mol Med (Berl) 93(11):1271–1281CrossRef
Fakih MG (2015) Metastatic colorectal cancer: current state and future directions. J Clin Oncol 33(16):1809–1824PubMedCrossRef
Feng S, Xiong L, Ji Z, Cheng W, Yang H (2011) Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer. Oncol Lett 2(5):899–903PubMedPubMedCentral
Formentini L, Sánchez-Aragó M, Sánchez-Cenizo L, Cuezva JM (2012) The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response. Mol Cell 45(6):731–742PubMedCrossRef
Gao J, Wen S, Zhou H, Feng S (2015) De-methylation of displacement loop of mitochondrial DNA is associated with increased mitochondrial copy number and nicotinamide adenine dinucleotide subunit 2 expression in colorectal cancer. Mol Med Rep 12(5):7033–7038PubMedCrossRef
Gasparre G, Porcelli AM, Lenaz G, Romeo G (2013) Relevance of mitochondrial genetics and metabolism in cancer development. Cold Spring Harb Perspect Biol 5(2):a011411PubMedPubMedCentralCrossRef
Gebb SA, Decoux A, Waggoner A, Wilson GL, Gillespie MN (2013) Mitochondrial DNA damage mediates hyperoxic dysmorphogenesis in rat fetal lung explants. Neonatology 103(2):91–97PubMedCrossRef
Geurts-Giele WR, Gathier GH, Atmodimedjo PN, Dubbink HJ, Dinjens WN (2015) Mitochondrial D310 mutation as clonal marker for solid tumors. Virchows Arch 467(5):595–602PubMedPubMedCentralCrossRef
Goto H, Dickins B, Afgan E, Paul IM, Taylor J, Makova KD, Nekrutenko A (2011) Dynamics of mitochondrial heteroplasmy in three families investigated via a repeatable re-sequencing study. Genome Biol 12(6):R59PubMedPubMedCentralCrossRef
Greaves LC, Preston SL, Tadrous PJ, Taylor RW, Barron MJ, Oukrif D, Leedham SJ, Deheragoda M, Sasieni P, Novelli MR, Jankowski JA, Turnbull DM, Wright NA, McDonald SA (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci USA 103(3):714–719PubMedPubMedCentralCrossRef
Guerra F, Perrone AM, Kurelac I, Santini D, Ceccarelli C, Cricca M, Zamagni C, De Iaco P, Gasparre G (2012) Mitochondrial DNA mutation in serous ovarian cancer: implications for mitochondria-coded genes in chemoresistance. J Clin Oncol 30(36):e373–e378PubMedCrossRef
Guo W, Zheng B, Cai Z, Xu L, Guo D, Cao L, Wang Y (2013) The polymorphic AluYb8 insertion in the MUTYH gene is associated with reduced type 1 protein expression and reduced mitochondrial DNA content. PLoS One 8(8):e70718PubMedPubMedCentralCrossRef
Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, Martinuzzi A, Hauswirth WW, Lewin AS (2002) Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol 52(5):534–542PubMedCrossRef
Habano W, Nakamura S, Sugai T (1998) Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene 17(15):1931–1937PubMedCrossRef
Hanes JW, Thal DM, Johnson KA (2006) Incorporation and replication of 8-oxo-deoxyguanosine by the human mitochondrial DNA polymerase. J Biol Chem 281(47):36241–36248PubMedCrossRef
Hashizume M, Mouner M, Chouteau JM, Gorodnya OM, Ruchko MV, Potter BJ, Wilson GL, Gillespie MN, Parker JC (2013) Mitochondrial-targeted DNA repair enzyme 8-oxoguanine DNA glycosylase 1 protects against ventilator-induced lung injury in intact mice. Am J Physiol Lung Cell Mol Physiol 304(4):L287–L297PubMedCrossRef
He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N (2010) Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464(7288):610–614PubMedPubMedCentralCrossRef
Hofhaus G, Attardi G (1995) Efficient selection and characterization of mutants of a human cell line which are defective in mitochondrial DNA-encoded subunits of respiratory NADH dehydrogenase. Mol Cell Biol 15(2):964–974PubMedPubMedCentralCrossRef
Hofmann JN, Hosgood HD 3rd, Liu CS, Chow WH, Shuch B, Cheng WL, Lin TT, Moore LE, Lan Q, Rothman N, Purdue MP (2014) A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial. Carcinogenesis 35(5):1028–1031PubMedPubMedCentralCrossRef
Horan MP, Cooper DN (2014) The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease. Hum Genet 133(4):435–458PubMedCrossRef
Huang WS, Kuo YH, Chin CC, Wang JY, Yu HR, Sheen JM, Tung SY, Shen CH, Chen TC, Sung ML, Liang HF, Kuo HC (2012) Proteomic analysis of the effects of baicalein on colorectal cancer cells. Proteomics 12(6):810–819PubMedCrossRef
Huang B, Gao YT, Shu XO, Wen W, Yang G, Li G, Courtney R, Ji BT, Li HL, Purdue MP, Zheng W, Cai Q (2014a) Association of leukocyte mitochondrial DNA copy number with colorectal cancer risk: results from the Shanghai Women’s Health Study. Cancer Epidemiol Biomark Prev 23(11):2357–2365CrossRef
Huang CY, Chen YM, Wu CH, Tsai CM, Lee YC, Perng RP, Whang-Peng J (2014b) Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung. Oncol Lett 7(6):2180–2184PubMedPubMedCentralCrossRef
Janeway KA, Kim SY, Lodish M, Nosé V, Rustin P, Gaal J et al (2011) Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci USA 108(1):314–318PubMedCrossRef
Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M et al (2015) Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res 25(6):814–824PubMedPubMedCentralCrossRef
Kaipparettu BA, Ma Y, Park JH, Lee TL, Zhang Y, Yotnda P, Creighton CJ, Chan WY, Wong LJ (2013) Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PLoS One 8(5):e61747PubMedPubMedCentralCrossRef
Kang KA, Zhang R, Kim GY, Bae SC, Hyun JW (2012) Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol 33(2):403–412PubMedCrossRef
Kassem AM, El-Guendy N, Tantawy M, Abdelhady H, El-Ghor A, Abdel Wahab AH (2011) Mutational hotspots in the mitochondrial D-loop region of cancerous and precancerous colorectal lesions in Egyptian patients. DNA Cell Biol 30(11):899–906PubMedPubMedCentralCrossRef
Kloss-Brandstätter A, Weissensteiner H, Erhart G, Schäfer G, Forer L, Schönherr S et al (2015) Validation of next-generation sequencing of entire mitochondrial genomes and the diversity of mitochondrial dna mutations in oral squamous cell carcinoma. PLoS One 10(8):e0135643PubMedPubMedCentralCrossRef
Koehler BC, Jäger D, Schulze-Bergkamen H (2014) Targeting cell death signaling in colorectal cancer: current strategies and future perspectives. World J Gastroenterol 20(8):1923–1934PubMedPubMedCentralCrossRef
Larman TC, DePalma SR, Hadjipanayis AG, Cancer Genome Atlas Research Network, Protopopov A, Zhang J, Gabriel SB, Chin L, Seidman CE, Kucherlapati R, Seidman JG (2012) Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci USA 109(35):14087–14091PubMedCrossRef
LeDoux SP, Druzhyna NM, Hollensworth SB, Harrison JF, Wilson GL (2007) Mitochondrial DNA repair: a critical player in the response of cells of the CNS to genotoxic insults. Neuroscience 145(4):1249–1259PubMedCrossRef
Lee JH, Hwang I, Kang YN, Choi IJ, Kim DK (2015) Genetic characteristics of mitochondrial DNA was associated with colorectal carcinogenesis and its prognosis. PLoS One 10(3):e0118612PubMedPubMedCentralCrossRef
Lehtonen R, Kiuru M, Vanharanta S, Sjöberg J, Aaltonen LM, Aittomäki K et al (2004) Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 164(1):17–22PubMedPubMedCentralCrossRef
Li M, Schönberg A, Schaefer M, Schroeder R, Nasidze I, Stoneking M (2010) Detecting heteroplasmy from high-throughput sequencing of complete human mitochondrial DNA genomes. Am J Hum Genet 87(2):237–249PubMedPubMedCentralCrossRef
Li WL, Xiao MS, Zhang DF, Yu D, Yang RX, Li XY, Yao YG (2014) Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer. Gene 546(2):263–270PubMedCrossRef
Linkowska K, Jawień A, Marszałek A, Malyarchuk BA, Tońska K, Bartnik E, Skonieczna K, Grzybowski T (2015) Mitochondrial DNA polymerase γ mutations and their implications in mtDNA alterations in colorectal cancer. Ann Hum Genet. doi:10.​1111/​ahg.​12111 PubMedCrossRef
Liu Y, Li Y, Wang H, Yu J, Lin H, Xu D et al (2009) BH3-based fusion artificial peptide induces apoptosis and targets human colon cancer. Mol Ther 17(9):1509–1516PubMedPubMedCentralCrossRef
Lu H, Busch J, Jung M, Rabenhorst S, Ralla B, Kilic E, Mergemeier S, Budach N, Fendler A, Jung K (2016) Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients. Clin Chim Acta 452:109–119PubMedCrossRef
Maillet A, Yadav S, Loo YL, Sachaphibulkij K, Pervaiz S (2013) A novel osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma. Cell Death Dis 4:e653PubMedPubMedCentralCrossRef
Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J, Schon EA (2002) Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet 30(4):394–399PubMedCrossRef
Máximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simões M (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol 160(5):1857–1865PubMedPubMedCentralCrossRef
McFarland CD, Korolev KS, Kryukov GV, Sunyaev SR, Mirny LA (2013) Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci USA 110(8):2910–2915PubMedPubMedCentralCrossRef
Mehrabi S, Akwe JA, Adams G Jr, Grizzle W, Yao X, Aikhionbare FO (2010) Analysis of mtDNA sequence variants in colorectal adenomatous polyps. Diagn Pathol 5:66PubMedPubMedCentralCrossRef
Nagahashi M, Wakai T, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T et al (2016) Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine. Genome Med 8(1):136PubMedPubMedCentralCrossRef
Park JS, Sharma LK, Li H, Xiang R, Holstein D, Wu J, Lechleiter J, Naylor SL, Deng JJ, Lu J, Bai Y (2009) A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 18(9):1578–1589PubMedPubMedCentralCrossRef
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807–1812PubMedPubMedCentralCrossRef
Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Krönke J, Bullinger L et al (2010) IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J Clin Oncol 28(22):3636–3643PubMedCrossRef
Pereira L, Soares P, Radivojac P, Li B, Samuels DC (2011) Comparing phylogeny and the predicted pathogenicity of protein variations reveals equal purifying selection across the global human mtDNA diversity. Am J Hum Genet 88(4):433–439PubMedPubMedCentralCrossRef
Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20(3):291–293PubMedCrossRef
Qu F, Chen Y, Wang X, He X, Ren T, Huang Q, Zhang J, Liu X, Guo X, Gu J, Xing J (2015) Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Carcinogenesis 36(5):543–552PubMedCrossRef
Rachek LI, Grishko VI, Alexeyev MF, Pastukh VV, LeDoux SP, Wilson GL (2004) Endonuclease III and endonuclease VIII conditionally targeted into mitochondria enhance mitochondrial DNA repair and cell survival following oxidative stress. Nucleic Acids Res 32(10):3240–3247PubMedPubMedCentralCrossRef
Rachek LI, Thornley NP, Grishko VI, LeDoux SP, Wilson GL (2006) Protection of INS-1 cells from free fatty acid-induced apoptosis by targeting hOGG1 to mitochondria. Diabetes 55(4):1022–1028PubMedCrossRef
Ramos A, Santos C, Mateiu L, Gonzalez Mdel M, Alvarez L, Azevedo L, Amorim A, Aluja MP (2013) Frequency and pattern of heteroplasmy in the complete human mitochondrial genome. PLoS One 8(10):e74636PubMedPubMedCentralCrossRef
Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F, Maher ER (2008) Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 100(17):1260–1262PubMedCrossRef
Ro S, Ma HY, Park C, Ortogero N, Song R, Hennig GW, Zheng H, Lin YM, Moro L, Hsieh JT, Yan W (2013) The mitochondrial genome encodes abundant small noncoding RNAs. Cell Res 23(6):759–774PubMedPubMedCentralCrossRef
Rubio CA (2016) Traditional serrated adenomas of the upper digestive tract. J Clin Pathol 69(1):1–5PubMedCrossRef
Salas A, García-Magariños M, Logan I, Bandelt HJ (2014) The saga of the many studies wrongly associating mitochondrial DNA with breast cancer. BMC Cancer 14:659PubMedPubMedCentralCrossRef
Saunders W (2005) Centrosomal amplification and spindle multipolarity in cancer cells. Semin Cancer Biol 15(1):25–32PubMedCrossRef
Schwartz S Jr, Alazzouzi H, Perucho M (2006) Mutational dynamics in human tumors confirm the neutral intrinsic instability of the mitochondrial D-loop poly-cytidine repeat. Genes Chromosomes Cancer 45(8):770–780PubMedCrossRef
Sharma LK, Fang H, Liu J, Vartak R, Deng J, Bai Y (2011) Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation. Hum Mol Genet 20(23):4605–4616PubMedPubMedCentralCrossRef
Simões RV, Serganova IS, Kruchevsky N, Leftin A, Shestov AA, Thaler HT, Sukenick G, Locasale JW, Blasberg RG, Koutcher JA, Ackerstaff E (2015) Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment. Neoplasia 17(8):671–684PubMedPubMedCentralCrossRef
Singh KK, Kulawiec M, Still I, Desouki MM, Geradts J, Matsui S (2005) Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354:140–146PubMedCrossRef
Smiraglia DJ, Kulawiec M, Bistulfi GL, Gupta SG, Singh KK (2008) A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther 7(8):1182–1190PubMedPubMedCentralCrossRef
Sondheimer N, Glatz CE, Tirone JE, Deardorff MA, Krieger AM, Hakonarson H (2011) Neutral mitochondrial heteroplasmy and the influence of aging. Hum Mol Genet 20(8):1653–1659PubMedPubMedCentralCrossRef
Sosa MX, Sivakumar IK, Maragh S, Veeramachaneni V, Hariharan R, Parulekar M et al (2012) Next-generation sequencing of human mitochondrial reference genomes uncovers high heteroplasmy frequency. PLoS Comput Biol 8(10):e1002737PubMedPubMedCentralCrossRef
Tachibana M, Amato P, Sparman M, Woodward J, Sanchis DM, Ma H et al (2013) Towards germline gene therapy of inherited mitochondrial diseases. Nature 493(7434):627–631PubMedCrossRef
Tanaka M, Borgeld HJ, Zhang J, Muramatsu S, Gong JS, Yoneda M et al (2002) Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J Biomed Sci 9(6 Pt 1):534–541PubMed
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11–22PubMedPubMedCentralCrossRef
Thyagarajan B, Wang R, Barcelo H, Koh WP, Yuan JM (2012) Mitochondrial copy number is associated with colorectal cancer risk. Cancer Epidemiol Biomark Prev 21(9):1574–1581CrossRef
Thyagarajan B, Guan W, Fedirko V, Barcelo H, Tu H, Gross M, Goodman M, Bostick RM (2016) No association between mitochondrial DNA copy number and colorectal adenomas. Mol Carcinog 55(8):1290–1296PubMedCrossRef
Tipirisetti NR, Govatati S, Pullari P, Malempati S, Thupurani MK, Perugu S, Guruvaiah P, Rao KL, Digumarti RR, Nallanchakravarthula V, Bhanoori M, Satti V (2014) Mitochondrial control region alterations and breast cancer risk: a study in South Indian population. PLoS One 9(1):e85363PubMedPubMedCentralCrossRef
van Gisbergen MW, Voets AM, Starmans MH, de Coo IF, Yadak R, Hoffmann RF, Boutros PC, Smeets HJ, Dubois L, Lambin P (2015) How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res Rev Mutat Res 764:16–30PubMedCrossRef
van Osch FH, Voets AM, Schouten LJ, Gottschalk RW, Simons CC, van Engeland M, Lentjes MH, van den Brandt PA, Smeets HJ, Weijenberg MP (2015) Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival. Carcinogenesis 36(12):1502–1510PubMed
Venderbosch S, van Vliet S, Craenmehr MH, Simmer F, de Haan AF, Punt CJ, Koopman M, Nagtegaal ID (2015) Mitochondrial microsatellite instability in patients with metastatic colorectal cancer. Virchows Arch 466(5):495–502PubMedPubMedCentralCrossRef
Venesio T, Balsamo A, Errichiello E, Ranzani GN, Risio M (2013) Oxidative DNA damage drives carcinogenesis in MUTYH-associated-polyposis by specific mutations of mitochondrial and MAPK genes. Mod Pathol 26(10):1371–1381PubMedCrossRef
Wallace DC, Chalkia D (2013) Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol 5(11):a021220PubMedPubMedCentralCrossRef
Wang C, Zhao S, Du Y, Guo Z (2016) Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with colorectal cancer outcome. Mitochondrial DNA A DNA Mapp Seq Anal 27(6):4361–4363PubMed
Webb E, Broderick P, Chandler I, Lubbe S, Penegar S, Tomlinson IP, Houlston RS (2008) Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk. Br J Cancer 99(12):2088–2093PubMedPubMedCentralCrossRef
Wickramasekera NT, Das GM (2014) Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication. Mitochondrion 16:26–37PubMedCrossRef
Wilson TR, McEwan M, McLaughlin K, Le Clorennec C, Allen WL, Fennell DA, Johnston PG, Longley DB (2009) Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells. Oncogene 28(1):63–72PubMedCrossRef
Wong LJ (2013) Next generation molecular diagnosis of mitochondrial disorders. Mitochondrion 13(4):379–387PubMedCrossRef
Woo DK, Green PD, Santos JH, D’Souza AD, Walther Z, Martin WD, Christian BE, Chandel NS, Shadel GS (2012) Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice. Am J Pathol 180(1):24–31PubMedPubMedCentralCrossRef
Yakes FM, Van Houten B (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 94(2):514–519PubMedPubMedCentralCrossRef
Yan B, Stantic M, Zobalova R, Bezawork-Geleta A, Stapelberg M, Stursa J, Prokopova K, Dong L, Neuzil J (2015) Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner. BMC Cancer 15:401PubMedPubMedCentralCrossRef
Yan B, Dong L, Neuzil J (2016) Mitochondria: an intriguing target for killing tumour-initiating cells. Mitochondrion 26:86–93PubMedCrossRef
Yang XM, Cui L, White J, Kuck J, Ruchko MV, Wilson GL, Alexeyev M, Gillespie MN, Downey JM, Cohen MV (2015) Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion. Basic Res Cardiol 110(2):3PubMedPubMedCentralCrossRef
Ye K, Lu J, Ma F, Keinan A, Gu Z (2014) Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals. Proc Natl Acad Sci USA 111(29):10654–10659PubMedPubMedCentralCrossRef
Yu M (2012) Circulating cell-free mitochondrial DNA as a novel cancer biomarker: opportunities and challenges. Mitochondrial DNA 23(5):329–332PubMedCrossRef
Yuzefovych LV, Kahn AG, Schuler MA, Eide L, Arora R, Wilson GL, Tan M, Rachek LI (2016) Mitochondrial DNA Repair through OGG1 Activity Attenuates Breast Cancer Progression and Metastasis. Cancer Res 76(1):30–34PubMedCrossRef
Metadata
Title
Mitochondrial DNA variants in colorectal carcinogenesis: Drivers or passengers?
Authors
Edoardo Errichiello
Tiziana Venesio
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 10/2017
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2418-2

Other articles of this Issue 10/2017

Journal of Cancer Research and Clinical Oncology 10/2017 Go to the issue

Original Article – Clinical Oncology

Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors

Original Article – Clinical Oncology

Survival of melanoma patients treated with novel drugs: retrospective analysis of real-world data

Original Article – Cancer Research

MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer

Review – Clinical Oncology

Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue

Original Article – Clinical Oncology

Clinical course and end-of-life care in patients who have died after allogeneic stem cell transplantation

Letter to the Editor

Response to “Commentary on: Undertreatment trend in elderly lung cancer patients in Brazil”—Jing-lan Tang, Chun-jie Hou
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits